Generate Biomedicines, Inc.

GENB

GENBGenerate Biomedicines, Inc. US flag

NASDAQ Global Market

12.91

USD

+0.94

- -

1.65BMarket Cap

Profitability (USD)

API Chat

	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-47.89
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	100	100
EBITDA Margin (%)	-887.58	-695.72
Operating Margin (%)	-962.6	-737.04
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	-885.54	-698.59
Profit Margin (%)	-849.36	-636.99
Net Income to Common Margin (%)	-1,044.9	-782.38
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	17.47	16.04
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

API Chat

	2024 Y	2025 Y
Total Debt	77	69
ST Debt	17	15
LT Debt	60	54
Total Debt/EBITDA	-0.42	-0.31
Net Debt/EBITDA	0.97	0.55
Total Debt/EBIT	-0.39	-0.29
Net Debt/EBIT	0.9	0.52
EBITDA to Interest Expense	-85.74	-195.32
EBITDA-CapEx/Interest Expense	-87.36	-198.42
EBIT to Interest Expense	-92.98	-206.92
Interest Expense	2	1
Common Equity/Total Assets	-91.29	-204.81
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-15.19	-8.7
Long-Term Debt/Total Assets (%)	11.63	16.21
Total Debt/Equity (%)	-17.69	-11
Total Debt/Capital (%)	-19.4	-11.14
Total Debt/Total Assets (%)	14.85	20.75
Net Debt to Equity	40.51	19.52
Net Debt/Capital (%)	30.76	16.51
EBITDA	-182	-222
EBITDA-CapEx	-185	-225
Operating Income (Loss)	-197	-235

Liquidity (USD)

API Chat

	2024 Y	2025 Y
Cash Ratio	4.54	2.69
Current Ratio	4.7	2.85
Quick Ratio	4.55	2.69
CFO/Avg Current Liab	- -	-2.38
Common Equity/Total Assets	-91.29	-204.81
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-15.19	-8.7
Long-Term Debt/Total Assets (%)	11.63	16.21
Total Debt/Equity (%)	-17.69	-11
Total Debt/Capital (%)	-19.4	-11.14
Total Debt/Total Assets (%)	14.85	20.75
CFO/Total Liabilities	-12.35	-21.04
CFO/CapEx	-34.16	-57.09
Altman's Z-Score	-1.75	-4.57

Working Capital (USD)

API Chat

	2024 Y	2025 Y
Accounts Receivable Turnover	- -	207.1
Days Sales Outstanding	- -	1.76
Inventory Turnover	- -	- -
Days Inventory Outstanding	- -	- -
Accounts Payable Turnover	- -	- -
Accounts Payable Turnover Days	- -	- -
Cash Conversion Cycle	- -	- -
Inventory to Cash Days	- -	- -
Inventories	- -	- -
Raw Materials	- -	- -
Work In Process	- -	- -
Finished Goods	- -	- -
Other Inventory	- -	- -

Enterprise Value (USD)

API Chat

	2024 Y	2025 Y
Market Capitalization	- -	- -
- Cash & Cash Equivalents	176	122
+ Preferred Equity and Hybrid Capital	- -	- -
+ Minority/Non Controlling Interest	-1	-7
+ Total Debt	77	69
Enterprise Value	-317	-160
Total Capital	-397	-615
Total Debt/Capital (%)	-19.4	-11.14
Total Debt / EV	-0.24	-0.43
EV/Sales	- -	- -
EV/EBITDA	- -	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	- -
Diluted Market Cap	- -	- -
Diluted Enterprise Value	-100	-60
EV per Share	- -	- -
TTM Sales	20	32
TTM EBITDA	-182	-222
TTM Operating Income	-197	-235
TTM Cash Flow to Firm	-116	-199
TTM Free Cash Flow to Firm	-112	-196

Multiples (USD)

API Chat

	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -
EV/EBIT	- -	- -
Enterprise Value	-317	-160
Low Price	- -	- -
EV/Sales	- -	- -
EV/EBITDA	- -	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	- -
Price/Earnings High	- -	- -
Price/Earnings Low	- -	- -
Price/Book Value	- -	- -
Price/Book Value Average	- -	- -
Price/Book Value High	- -	- -
Price/Book Value Low	- -	- -
Price/Tangible Book Value	- -	- -
Price/Tangible Book Value Average	- -	- -
Price/Tangible Book Value High	- -	- -
Price/Tangible Book Value Low	- -	- -
Price/Sales	- -	- -
Price/Sales Average	- -	- -
Price/Sales High	- -	- -
Price/Sales Low	- -	- -
Price/Cash Flow	- -	- -
Price/Cash Flow Average	- -	- -
Price/Cash Flow High	- -	- -
Price/Cash Flow Low	- -	- -
Price/Free Cash Flow Average	- -	- -
Price/Free Cash Flow High	- -	- -
Price/Free Cash Flow Low	- -	- -
EV/Sales Average	- -	- -
EV/Sales High	- -	- -
EV/Sales Low	- -	- -
EV/EBITDA Average	0.55	0.27
EV/EBITDA High	0.55	0.27
EV/EBITDA Low	0.55	0.27
EV/EBIT Average	0.51	0.26
EV/EBIT High	0.51	0.26
EV/EBIT Low	0.51	0.26
Last Price	- -	- -
High Price	- -	- -
Enterprise Value Average	-100	-60
Enterprise Value High	-100	-60
Enterprise Value Low	-100	-60

Profitability (USD)

API Chat

	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-47.89
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	100	100
EBITDA Margin (%)	-887.58	-695.72
Operating Margin (%)	-962.6	-737.04
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	-885.54	-698.59
Profit Margin (%)	-849.36	-636.99
Net Income to Common Margin (%)	-1,044.9	-782.38
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	17.47	16.04
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

API Chat

	2024 Y	2025 Y
Total Debt	77	69
ST Debt	17	15
LT Debt	60	54
Total Debt/EBITDA	-0.42	-0.31
Net Debt/EBITDA	0.97	0.55
Total Debt/EBIT	-0.39	-0.29
Net Debt/EBIT	0.9	0.52
EBITDA to Interest Expense	-85.74	-195.32
EBITDA-CapEx/Interest Expense	-87.36	-198.42
EBIT to Interest Expense	-92.98	-206.92
Interest Expense	2	1
Common Equity/Total Assets	-91.29	-204.81
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-15.19	-8.7
Long-Term Debt/Total Assets (%)	11.63	16.21
Total Debt/Equity (%)	-17.69	-11
Total Debt/Capital (%)	-19.4	-11.14
Total Debt/Total Assets (%)	14.85	20.75
Net Debt to Equity	40.51	19.52
Net Debt/Capital (%)	30.76	16.51
EBITDA	-182	-222
EBITDA-CapEx	-185	-225
Operating Income (Loss)	-197	-235

Liquidity (USD)

API Chat

	2024 Y	2025 Y
Cash Ratio	4.54	2.69
Current Ratio	4.7	2.85
Quick Ratio	4.55	2.69
CFO/Avg Current Liab	- -	-2.38
Common Equity/Total Assets	-91.29	-204.81
Long-Term Debt/Equity (%)	- -	- -
Long-Term Debt/Capital (%)	-15.19	-8.7
Long-Term Debt/Total Assets (%)	11.63	16.21
Total Debt/Equity (%)	-17.69	-11
Total Debt/Capital (%)	-19.4	-11.14
Total Debt/Total Assets (%)	14.85	20.75
CFO/Total Liabilities	-12.35	-21.04
CFO/CapEx	-34.16	-57.09
Altman's Z-Score	-1.75	-4.57

Working Capital (USD)

API Chat

	2024 Y	2025 Y
Accounts Receivable Turnover	- -	207.1
Days Sales Outstanding	- -	1.76
Inventory Turnover	- -	- -
Days Inventory Outstanding	- -	- -
Accounts Payable Turnover	- -	- -
Accounts Payable Turnover Days	- -	- -
Cash Conversion Cycle	- -	- -
Inventory to Cash Days	- -	- -
Inventories	- -	- -
Raw Materials	- -	- -
Work In Process	- -	- -
Finished Goods	- -	- -
Other Inventory	- -	- -

Enterprise Value (USD)

API Chat

	2024 Y	2025 Y
Market Capitalization	- -	- -
- Cash & Cash Equivalents	176	122
+ Preferred Equity and Hybrid Capital	- -	- -
+ Minority/Non Controlling Interest	-1	-7
+ Total Debt	77	69
Enterprise Value	-317	-160
Total Capital	-397	-615
Total Debt/Capital (%)	-19.4	-11.14
Total Debt / EV	-0.24	-0.43
EV/Sales	- -	- -
EV/EBITDA	- -	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	- -
Diluted Market Cap	- -	- -
Diluted Enterprise Value	-100	-60
EV per Share	- -	- -
TTM Sales	20	32
TTM EBITDA	-182	-222
TTM Operating Income	-197	-235
TTM Cash Flow to Firm	-116	-199
TTM Free Cash Flow to Firm	-112	-196

Multiples (USD)

API Chat

	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -
EV/EBIT	- -	- -
Enterprise Value	-317	-160
Low Price	- -	- -
EV/Sales	- -	- -
EV/EBITDA	- -	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	- -
Price/Earnings High	- -	- -
Price/Earnings Low	- -	- -
Price/Book Value	- -	- -
Price/Book Value Average	- -	- -
Price/Book Value High	- -	- -
Price/Book Value Low	- -	- -
Price/Tangible Book Value	- -	- -
Price/Tangible Book Value Average	- -	- -
Price/Tangible Book Value High	- -	- -
Price/Tangible Book Value Low	- -	- -
Price/Sales	- -	- -
Price/Sales Average	- -	- -
Price/Sales High	- -	- -
Price/Sales Low	- -	- -
Price/Cash Flow	- -	- -
Price/Cash Flow Average	- -	- -
Price/Cash Flow High	- -	- -
Price/Cash Flow Low	- -	- -
Price/Free Cash Flow Average	- -	- -
Price/Free Cash Flow High	- -	- -
Price/Free Cash Flow Low	- -	- -
EV/Sales Average	- -	- -
EV/Sales High	- -	- -
EV/Sales Low	- -	- -
EV/EBITDA Average	0.55	0.27
EV/EBITDA High	0.55	0.27
EV/EBITDA Low	0.55	0.27
EV/EBIT Average	0.51	0.26
EV/EBIT High	0.51	0.26
EV/EBIT Low	0.51	0.26
Last Price	- -	- -
High Price	- -	- -
Enterprise Value Average	-100	-60
Enterprise Value High	-100	-60
Enterprise Value Low	-100	-60

	2024 Y	2025 Y
Shares Outstanding	127	127
Diluted Weighted Avg Shares	102	102
Basic Weighted Avg Shares	102	102
Revenue per Share	0.2	0.31
EBITDA per Share	-1.77	-2.17
Operating Income per Share	-1.92	-2.3
Basic EPS, GAAP	-2.09	-2.44
Basic EPS from Cont Ops	-1.77	-2.18
Diluted EPS, GAAP	-2.09	-2.44
Diluted EPS from Cont Ops	-1.77	-2.18
Dividend per Share	- -	- -
Cash Flow per Share	-1.15	-1.96
Free Cash Flow per Basic Share	-1.18	-2
Cash & Equivalents per Share	3.85	2.17
Book Value per Share	-4.62	-6.61
Tangible Book Value per Share	-4.25	-6.09

Generate Biomedicines, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)